This announcement is a separate document:
康希諾生物-B：建議採納2021年限制性股票激勵計劃及建議根據特別授權發行限制性股票；建議採納2021年限制性股票激勵計劃實施考覈管理辦法；建議授權董事會處理2021年限制性股票激勵計劃相關事項；及暫停辦理H股股份過戶登記手續
CANSINOBIO-B: PROPOSED ADOPTION OF THE 2021 RESTRICTED SHARE INCENTIVE SCHEME AND PROPOSED ISSUE OF RESTRICTED SHARES PURSUANT TO SPECIFIC MANDATE; PROPOSED ADOPTION OF THE MANAGEMENT MEASURES FOR ASSESSMENT FOR THE IMPLEMENTATION OF THE 2021 RESTRICTED S
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.